Trial record 5 of 9 for: "Hereditary Antithrombin Deficiency" | "HIV Protease Inhibitors"
Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01547728|
Recruitment Status : Terminated (Too many barriers to enroll participants.)
First Posted : March 8, 2012
Results First Posted : July 15, 2015
Last Update Posted : July 15, 2015
Information provided by (Responsible Party):
William C. Oliver, Mayo Clinic
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Thrombophilia Due to Acquired Antithrombin III Deficiency
Drug: Recombinant antithrombin (rhAT)
|Recruitment Details||Subjects were recruited from Mayo Clinic in Rochester, Minnesota.|
The study was terminated because there were too many barriers to enroll participants.